Suchergebnisse - "Mugerwa, Henry"

PubPharm (33)

1

Effect of Neutralizing Monoclonal Antibody Treatment on Early Trajectories of Virologic and Immunologic Biomarkers in Patients Hospitalized With COVID-19

enthalten in: The Journal of infectious diseases | 2024

von Jensen, T. | Grandits, G. | Jain, M. | +131

2

Pharmacokinetics and safety of twice-daily ritonavir-boosted atazanavir with rifampicin

enthalten in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America | 2023

von Gausi, K. | Mugerwa, H. | Siccardi, M. | +12

3

Rosuvastatin adjunctive therapy for rifampicin-susceptible pulmonary tuberculosis : a phase 2b, randomised, open-label, multicentre trial

enthalten in: The Lancet. Infectious diseases | 2023

von Cross, G. | Sari, I. | Kityo, C. | +46

4

Correction : Towards access for all: 1st Working Group Report for the Global Gene Therapy Initiative (GGTI)

enthalten in: Gene therapy | 2023

von Adair, J. | Androski, L. | Bayigga, L. | +25

ErratumFor: Gene Ther. 2023 Apr;30(3-4):216-221. - PMID 34493840

5

Towards access for all : 1st Working Group Report for the Global Gene Therapy Initiative (GGTI)

enthalten in: Gene therapy | 2023

von Adair, J. | Androski, L. | Bayigga, L. | +25

ErratumIn: Gene Ther. 2021 Sep 29;:. - PMID 34584245

6

Prevalence and Factors Associated with Renal Disease Among HIV Infected Children on Antiretroviral Therapy Attending Joint Clinical Research Center, Lubowa, Kampala

enthalten in: bioRxiv.org | 2023

von Bagoloire, L. | Sheilla, A. | Kalyango, J. | +5

7

Antiretroviral Initiation at ≥800 CD4+ Cells/mm3 Associated With Lower Human Immunodeficiency Virus Reservoir Size

enthalten in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America | 2022

von Ahuja, S. | Kuwanda, L. | Vjecha, M. | +24

8

Lessons from an international trial evaluating vaccination strategies for recovered inpatients with COVID-19 (VATICO)

enthalten in: Med (New York, N.Y.) | 2022

von Mylonakis, E. | Lutaakome, J. | Jain, M. | +29

9

Efficacy and safety of dolutegravir or darunavir in combination with lamivudine plus either zidovudine or tenofovir for second-line treatment of HIV infection (NADIA) : week 96 results from a prospective, multicentre, open-label, factorial, randomised, non-inferiority trial

enthalten in: The lancet. HIV | 2022

von Paton, N. | Musaazi, J. | Kityo, C. | +101

CommentIn: Lancet HIV. 2022 Jun;9(6):e368-e369. - PMID 35460602

10

Efficacy of Cipargamin (KAE609) in a Randomized, Phase II Dose-Escalation Study in Adults in Sub-Saharan Africa With Uncomplicated Plasmodium falciparum Malaria

enthalten in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America | 2022

von Schmitt, E. | Ndayisaba, G. | Yeka, A. | +17